Medical Radiology and Radiation Safety. 2024. Vol. 69. № 6

DOI:10.33266/1024-6177-2024-69-6-77-81

D.A. Ginevsky, P.V. Izhevskij, T.N. Laschenova

Stochastic Model of the Processe of the Spread of Platinum Drugs in Tumor Tissues

A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia

Contact person: D.A. Ginevsky, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

ABSTRACT

Purpose: The study of the kinetics of the spatio-temporal distribution of cisplatin, as an agent capable of increasing the effectiveness of chemo-radiation therapy of solid tumors. 

Material and methods: The material was the data of literature on the results of experiments of various groups of authors who studied the content of platinum in tissues on biopsy materials. The method of simulation mathematical modeling (in silico) is used, based on the biological patterns of tumor growth, morphofunctional changes in the structure of tumor cells and tissues. Model is based on reaction-diffusion equation system, coefficients of which are random functions of space and time. The model takes into account the sequence of processes from intravenous administration of cisplatin and its spatial distribution in various tissues, until the excretion of its addicts from the cell.

Results: The heterogeneity of the distribution of the concentration of platinum atoms in the tumor is shown. Perhaps this is due to the varying degree of vascularization of tissues, the rate of metabolism of the tumor occurring in the outer layer and in its hypoxic core. These processes lead to significant errors when evaluating the biopsy data obtained in the experiments and the analysis of platinum content in the biopsy.

Conclusions: The calculation assessments of the distribution of platinum atoms in the tumor are consistent with the literature on the concentration of cisplatin in biopsy samples for carcinoma. The results of the calculations on the described model are fair, taking into account the morphological type, the size of the tumor and the plan of the administration of the drug. For other conditions (cancer types, treatment regimens, etc.), new calculations are necessary. To increase the efficiency of combined chemo-radiation therapy, cisplatin should be introduced at least 72 hours before the start of radiation therapy.

Keywords: cemo-radiation therapy, cislatin, tumors, mathematical modeling

For citation: Ginevsky DA, Izhevskij PV, Laschenova TN. Stochastic Model of the Processe of the Spread of Platinum Drugs in Tumor Tissues. Medical Radiology and Radiation Safety. 2024;69(6):77–81. (In Russian). DOI:10.33266/1024-6177-2024-69-6-77-81

References

1. Zlokachestvennyye Novoobrazovaniya v Rossii v 2022 Godu (Zabolevayemost’ i Smertnost’)=Malignant Neoplasms in Russia in 2022 (Incidence and Mortality). Ed. A.D.Kaprin. Moscow, National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation  Publ., 2023. 275 p. (In Russ.). 

2. Bucci МК, Bevan A, Roach М. Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D and Beyond. СA Cancer Clin. 2005;55;2:117–34.

3. Sukhikh Е.S., Sukhikh L.G., Anikeyeva O.YU., Izhevs-
kiy P.V., Sheyno I.N. Dosimetric Evaluation for Various Methods of Combined Radiotherapy of Cervical Cancer. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’= Medical Radiology and Radiation Safety. 2019;64;1:45-52
(In Russ.). doi: 10.12737/article_5c55fb4a074ee1.27347494

4. Dar’yalova S.L., et al. The Use of Antitumor Drugs as Modifiers of the Reaction of Malignant Tumors to Radiation Therapy. Sovremennyye Tendentsii Razvitiya Lekarstvennoy Terapii Opukholey = Modern Trends in the Development of Drug Therapy for Tumors. Moscow Publ., 1998. 76 p.
(In Russ.).

5. Bolotina L.V., Vladimirova L.YU., Den’gina N.V., Novik A.V., Romanov I.S. Practical Recommendations for the Treatment of Malignant Tumors of the Head and Neck. Malignant Tumors. 2016;452;55-63. (In Russ.). doi: 10.18027/2224-5057-2016-452-55-63

6. URL https://www.rlsnet.ru/drugs/cisplatin-ronc-58005 (accessed date: 25.05.2024). 

7. Grokhovskiy S. L., Zubarev V. Ye. Specific Cleavage of 2-Helix Dna Induced by Ionization of Platinum Atom by X-Ray Irradiation. Reports of the Academy of Sciences of the USSR Publ., 1990;313;6:1500-4 (In Russ.).

8. Ginevskiy A.F., Ginevskiy D.A., Izhevskiy P.V.  Numerical Modeling of Space-time Distribution of a Drug Agent in Biological Tissue. Mathematical Modeling. 2021;33;11:3-17. https://doi.org/10.20948/mm-2021-11-01

9. Biston М.С., Jouber A., Adam J.F., Elleaume H., Bohic H., Charvet A.M., Estève F., Foray N., Balosso J. Cure of Fisher Rats Bearing Radioresistant F98 Glioma Treated with cis-Platinum and Irradiated with Monochromatic Synchrotron X-Rays. Cancer Research. 2004;Apr 1;64:2317-23.

10. Zamboni W.C., Gervais A.C., Egorin M.J., Schellens J.H., Hamburger D.R., Delauter B.J., Grim A., Zuhowski E.G., Joseph E., Pluim D., Potter D.M., Eiseman J.L. Inter- and Intratumoral Disposition of Platinum in Solid Tumors after Administration of Cisplatin. Clin Cancer Res. 2002;Sep;8;9:2992-9. PMID: 12231546.

11. Tsyushi Ch. Konformatsionnyye Izmeneniya Molekuly Dnk pri Vzaimodeystvii s Koordinatsionnymi Soyedineniyami Platiny i Serebra = Conformational Changes in the DNA Molecule During Interaction with Coordination Compounds of Platinum and Silver. .Candidate’s Thesis (Physical and Mathematical Sciences). St. Petersburg Publ., 2015. 120 p. (In Russ.).

12. Akaboshi M., Kawai K., Maki H., Akuta K., Ujeno У., Miyahara T. The Number of Platinum Atoms Binding to DNA, RNA and Protein Molecules of HeLa Cells Treated with Cisplatin at Its Mean Lethal Concentration. Jpn. J. Cancer Res. 1992;Мау;83:522-6.

13. Holding JD, Lindup WE, Bowdler DA, Siodlak MZ, Stell PM. Disposition and Tumour Concentrations of Platinum in Hypoalbuminaemic Patients after Treatment with Cisplatin for Cancer of the Head and Neck. Br. J. Clin. Pharmac. 1991;32:173-9.

 PDF (RUS) Full-text article (in Russian)

Conflict of interest. The authors declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. Article was prepared with equal participation of the authors.

Article received: 20.07.2024. Accepted for publication: 25.09.2024.